Video

A Double-Edged Sword? Defining "Efficiency" In mRNA Process Development

Source: Advancing RNA

In this clip from a recent Advancing RNA LIVE event, Omega Therapeutics’ Jeff Atkinson and Sail Biomedicines’ Jim Nolan address an audience question about where the best opportunities exist upstream and/or downstream to increase mRNA manufacturing efficiencies. As the panelists elaborate, however, the answers to this question are far from straightforward today.  

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.

Subscribe to Advancing RNA X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Advancing RNA

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)